2 Best Biotech Stocks to Buy in December
Biotech stocks have been on fire for much of 2020. Indeed, the industry benchmark, iShares NASDAQ Biotechnology ETF (NASDAQ: IBB), is up more than 27% year to date. That's far better than the S&P 500's 14% return over the same period. There are also many companies within the ETF that are outperforming both benchmarks.
When it comes to this industry, valuation and revenue growth are critical. One needs to carefully balance the two and be careful not to pay too high a price even for the companies with most promising drug pipelines. Today, let's look at how two stocks, Regeneron Pharmaceuticals (NASDAQ: REGN) and Gilead Sciences (NASDAQ: GILD), meet these criteria and why they are among the best biotechs to buy in December.
Image source: Getty Images.
Source Fool.com
